DK1064018T3 - Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktioner - Google Patents
Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktionerInfo
- Publication number
- DK1064018T3 DK1064018T3 DK99914112T DK99914112T DK1064018T3 DK 1064018 T3 DK1064018 T3 DK 1064018T3 DK 99914112 T DK99914112 T DK 99914112T DK 99914112 T DK99914112 T DK 99914112T DK 1064018 T3 DK1064018 T3 DK 1064018T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- collagen
- type
- isolated
- tissue interactions
- Prior art date
Links
- 102000004266 Collagen Type IV Human genes 0.000 title abstract 3
- 108010042086 Collagen Type IV Proteins 0.000 title abstract 3
- 230000003993 interaction Effects 0.000 title 1
- 239000000178 monomer Substances 0.000 abstract 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000008614 cellular interaction Effects 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 210000002744 extracellular matrix Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- AIDS & HIV (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7978398P | 1998-03-27 | 1998-03-27 | |
| US10617098P | 1998-10-29 | 1998-10-29 | |
| EP99914112A EP1064018B1 (en) | 1998-03-27 | 1999-03-26 | The use of isolated domains of type iv collagen to modify cell and tissue interactions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1064018T3 true DK1064018T3 (da) | 2004-11-29 |
Family
ID=26762432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99914112T DK1064018T3 (da) | 1998-03-27 | 1999-03-26 | Anvendelsen af isolerede domæner af Type IV kollagen til at modificere celle- og vævsinteraktioner |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1064018B1 (da) |
| JP (1) | JP2002509895A (da) |
| AT (1) | ATE274351T1 (da) |
| AU (1) | AU748751B2 (da) |
| CA (1) | CA2318432C (da) |
| DE (1) | DE69919684T2 (da) |
| DK (1) | DK1064018T3 (da) |
| ES (1) | ES2224627T3 (da) |
| PT (1) | PT1064018E (da) |
| WO (1) | WO1999049885A2 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358735B1 (en) | 1995-06-30 | 2002-03-19 | University Of Kansas Medical Center | Method for inhibiting angiogenesis and tumors with the isolated NC1 α3 chain monomer of type IV collagen |
| US6440729B1 (en) | 1995-06-30 | 2002-08-27 | University Of Kansas Medical Center | Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen |
| WO2001051523A2 (en) * | 2000-01-07 | 2001-07-19 | Beth Israel Deaconess Medical Center | Anti-angiogenic proteins and fragments and methods of use thereof |
| US6962974B1 (en) | 1998-06-17 | 2005-11-08 | Beth Israel Deaconess Medical Center | Anti-angiogenic proteins and fragments and methods of use thereof |
| US7387779B2 (en) | 1998-06-17 | 2008-06-17 | Beth Israel Deaconess Medical Center | Anti-angiogenic proteins and fragments and methods of use thereof |
| US6759047B1 (en) | 1998-06-17 | 2004-07-06 | Beth Israel Deaconess Hospital Corp. | Anti-angiogenic proteins and methods of use thereof |
| AU4187200A (en) * | 1999-04-01 | 2000-10-23 | Biostratum, Inc. | The use of domains of type iv collagen t inhibit angiogenesis an tumour growth |
| CN100447155C (zh) * | 2001-05-23 | 2008-12-31 | 中国科学院上海上海生命科学研究院 | 具有抑制内皮细胞生长活性的重组人内皮生长抑制蛋白 |
| WO2003012122A2 (en) * | 2001-07-27 | 2003-02-13 | University Of Kansas Medical Center | Crystallized structure of type iv collagen nc1 domain hexamer |
| AU2003262277A1 (en) * | 2002-12-03 | 2004-06-23 | Koken Co., Ltd. | Inhibitor of proliferation and/or infiltration of tumor cells |
| JP2017532365A (ja) * | 2014-07-25 | 2017-11-02 | ゴールドフィンチ バイオファーマ，インク． | コラーゲンｉｖの置き換え |
| CN119751647B (zh) * | 2024-12-31 | 2025-08-12 | 江苏创健医疗科技股份有限公司 | 重组iv型胶原蛋白及其制备方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5567609A (en) * | 1994-06-30 | 1996-10-22 | University Of Kansas Medical Center | Use of isolated domains of type IV collagen to modify cell and tissue interactions |
| EP0857210B1 (en) * | 1995-10-23 | 2003-09-03 | The Children's Medical Center Corporation | Therapeutic antiangiogenic compositions and methods |
-
1999
- 1999-03-26 DK DK99914112T patent/DK1064018T3/da active
- 1999-03-26 WO PCT/US1999/006445 patent/WO1999049885A2/en not_active Ceased
- 1999-03-26 CA CA002318432A patent/CA2318432C/en not_active Expired - Fee Related
- 1999-03-26 AU AU32025/99A patent/AU748751B2/en not_active Ceased
- 1999-03-26 PT PT99914112T patent/PT1064018E/pt unknown
- 1999-03-26 EP EP99914112A patent/EP1064018B1/en not_active Expired - Lifetime
- 1999-03-26 AT AT99914112T patent/ATE274351T1/de not_active IP Right Cessation
- 1999-03-26 JP JP2000540848A patent/JP2002509895A/ja active Pending
- 1999-03-26 ES ES99914112T patent/ES2224627T3/es not_active Expired - Lifetime
- 1999-03-26 DE DE69919684T patent/DE69919684T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999049885A3 (en) | 1999-12-09 |
| ATE274351T1 (de) | 2004-09-15 |
| DE69919684D1 (de) | 2004-09-30 |
| WO1999049885A2 (en) | 1999-10-07 |
| ES2224627T3 (es) | 2005-03-01 |
| CA2318432C (en) | 2003-01-28 |
| AU3202599A (en) | 1999-10-18 |
| AU748751B2 (en) | 2002-06-13 |
| DE69919684T2 (de) | 2005-09-15 |
| PT1064018E (pt) | 2004-12-31 |
| EP1064018B1 (en) | 2004-08-25 |
| CA2318432A1 (en) | 1999-10-07 |
| JP2002509895A (ja) | 2002-04-02 |
| EP1064018A2 (en) | 2001-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60127656D1 (de) | Integrin antagonisten | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| ATE465748T1 (de) | Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung | |
| ATE382681T1 (de) | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen | |
| DE69133064D1 (de) | Identifizierung und expression von insekten-steroidrezeptor-dns-sequenzen | |
| TR199902818T2 (xx) | Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler. | |
| DE68927523D1 (de) | Modifikation der Domäne der Konstantregion der Antikörpern | |
| DE69919684D1 (de) | Verwendung von isolierten domänen des type-iv-kollagens zur änderung der zell- und gewebewechselwirkung | |
| EA199900162A1 (ru) | Ингибиторы клеточной адгезии | |
| EP1137658A4 (en) | METHOD FOR MODULATING TUMOR NECROSIS FACTOR -g (a) -INDUCTED EXPRESSION OF CELL ADHESION MOLECULES | |
| ATE398676T2 (de) | Antagonistische selektive bindungsagenzien des osteoprotegerin-bindungsproteins | |
| DE69934998D1 (de) | Antisense modulation der expression von integrin alpha 4 | |
| DE60232234D1 (de) | Verfahren zur kultivierung von circovirus | |
| ATE255420T1 (de) | Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung | |
| ATE400289T1 (de) | Verwendung vom vaskulären endothelialen wachstumsfaktor 2 (vegf-2) | |
| DK1007537T3 (da) | Receptor-protein med betegnelsen 2F1 | |
| SE0301087D0 (sv) | New monoclonal antibody | |
| ATE347611T1 (de) | Automatischer apparat zum messen von wassertoxizität | |
| ATE262537T1 (de) | Proliferationsinhibitor von endothellzellen und dessen verwendung | |
| ATE466020T1 (de) | Neue isoform des gefässendothelzell wachstumshemmers (vegi) | |
| TR200002955T2 (tr) | Antitümör aktivitesi olan spisülozin bileşimleri | |
| DE60329225D1 (de) | Botulinumneurotoxin-b-rezeptoren und ihreverwendung | |
| DK1051491T3 (da) | Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| ATE302273T1 (de) | Cadherin derived growth factor und seine verwendung |